Cargando…
Translating evidence into global impact: lessons for HIV research and policy development from the AMBITION Trial
Autores principales: | Jarvis, Joseph N, Chou, Roger, Harrison, Thomas S, Lawrence, David S, Muthoga, Charles, Mupeli, Kennedy, Meya, David B, Mwandumba, Henry C, Kanyama, Cecilia, Meintjes, Graeme, Leeme, Tshepo B, Ndhlovu, Chiratidzo E, Beattie, Pauline, Sued, Omar, Casas, Carmen Pérez, Makanga, Michael, Ford, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615252/ https://www.ncbi.nlm.nih.gov/pubmed/37858577 http://dx.doi.org/10.1016/S2214-109X(23)00412-6 |
Ejemplares similares
-
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial
por: Molefi, Mooketsi, et al.
Publicado: (2015) -
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
por: Lawrence, David S., et al.
Publicado: (2018) -
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
por: Lawrence, David S., et al.
Publicado: (2019) -
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?
por: Harrison, Thomas S, et al.
Publicado: (2022) -
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study
por: Ponatshego, Ponego Lloyd, et al.
Publicado: (2019)